FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)

NCT07497893 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation (AF)
Upper Gastrointestinal Bleeding (UGIB)
Gastrointestinal Hemorrhage (Clinically Important, Upper)
Drug-Related Side Effects and Adverse Reactions

Interventions

DRUG: Fexuprazan
DRUG: NOAC therapy

Sponsor

Ewha Womans University Mokdong Hospital